Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID‐19: A multi‐center, open‐label, randomized controlled trial
- Resource Type
- Article
- Source
- In
Journal of Thrombosis and Haemostasis September 2021 19(9):2225-2234 - Subject
- Language
- ISSN
- 1538-7836